Andreas Gille

Years Active: 2015-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

C Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, Gerald Chi, Adam T Phillips, Sahar Memar Montazerin, Danielle Duffy, Bo Zheng, Mark Heise, Charles Liss, Lawrence I Deckelbaum, Samuel D Wright, Andreas Gille
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Cecilie Morland, Krister A Andersson, Øyvind P Haugen, Alena Hadzic, Liv Kleppa, Andreas Gille, Johanne E Rinholm, Vuk Palibrk, Elisabeth H Diget, Lauritz H Kennedy, Tomas Stølen, Eivind Hennestad, Olve Moldestad, Yiqing Cai, Maja Puchades, Stefan Offermanns, Koen Vervaeke, Magnar Bjørås, Ulrik Wisløff, Jon Storm-Mathisen, Linda H Bergersen
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1. Nature communications 8 (2017)
Cong Tang, Kashan Ahmed, Andreas Gille, Shun Lu, Hermann-Josef Gröne, Sorin Tunaru, Stefan Offermanns
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nature medicine 21 (2) (2015)

Andreas Gille.css-eqlu8i{font-size:small;padding-left:4px;}